PROpranolol for Cerebral Hemorrhage-ASsociated pnEumonia (PRO-CHASE)

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

February 21, 2023

Primary Completion Date

December 18, 2024

Study Completion Date

March 11, 2025

Conditions
StrokeVascular AccidentIntracranial HemorrhagesIntracerebral HemorrhageHemorrhagic StrokeStroke, Acute
Interventions
DRUG

Propranolol Hydrochloride

"Day of randomization:~propranolol IV vp for 7 days after randomization"

OTHER

control group

Patients will receive usual care and drug use in hospital

Trial Locations (12)

100070

Beijing Tiantan Hospital,Capital Medical University, Beijing

213003

Third Affiliated Hospital, Soochow University, Changzhou

Unknown

Lu'an Hospital of Traditional Chinese Medicine, Lu'an

Weinan City Center hospital, Weinan

Tangdu Hospital,Air Force Medical University, Xi'an

Xi'an Central Hospital, Xi'an

Qianxian People's Hospital, Xianyang

The First People' Hospital of Xian Yang, Xianyang

Xianyang hospital affliated of Yan'an University, Xianyang

The 970th Hospital of the Chinese People's Liberation Army (Weihai Branch), Weihai

The 970th Hospital of the Chinese People's Liberation Army (Yantai Branch), Yantai

Tianjin Huanhu Hospital, Tianjin

All Listed Sponsors
lead

Beijing Tiantan Hospital

OTHER